Particle.news
Download on the App Store
4 ARTICLES
·
yesterday

Neuralink Raises $600 Million, Reaches $9 Billion Valuation

The brain implant holds FDA breakthrough status, enabling spinal injury patients to control computers with thought.

Image
Artistic images of the brain and action potentials happening in it.
Image
Image

Overview

  • The company closed a $600 million financing round this month, boosting its valuation from $3.5 billion in late 2023 to about $9 billion.
  • The U.S. Food and Drug Administration granted the implant a breakthrough device designation to accelerate its review and development.
  • Clinical trials have seen participants with spinal cord injuries use the chip to play video games, browse the internet and move a cursor purely through neural signals.
  • Since FDA approval for human trials in 2023, Neuralink has implanted multiple patients, including a non-verbal ALS volunteer who regained speech capabilities via the device.
  • Elon Musk has said he plans to expand the technology’s applications to treat conditions such as depression, obesity and autism in future iterations.